← Leaderboards
Phillip Brian Smith
Duke University
$108,296,899
Attributed
$125,762,780
Total exposure
17
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $52.5M · FY2009–25$100M$75M$50M$25M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$310,426,384 · 16
FDA$690,084 · 1
SAMHSA$0 · 1
By mechanism
U2C$308,731,937 · 12
R34$793,155 · 2
R01$690,084 · 1
R21$456,536 · 1
K23$444,756 · 1
R18$0 · 1
Top collaborators
- Laura Kristin Newby17 shared
- Daniel K Benjamin11 shared
- Linda S Adair7 shared
- Matthew Laughon2 shared
Most similar at Duke University
Same institution · by research overlap
- Laura Kristin Newby$29,253,723
- Joel Newman Meyer$9,536,221
- Daniel K Benjamin$109,874,279
- Kathleen Mullan Harris$60,779,304
- Marcy C. Speer$7,600,979
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodResearch InstituteClinical ResearchResearch DesignProgramsChildChild HealthOperationEnvironmental ExposureUniversitiesResearch PersonnelSiteProtocols DocumentationInnovationEnvironmental ImpactGrantResourcesLeadMonitorCollaborationsEnsureTrainingPediatric CohortCommunication
Grant awards (55)
Environmental influences on Child Health Outcomes (ECHO) Coordinating Center$13,999,997
U2C · FY2025 · OD · contact PI
Coordinating Center Administration Core$7,002,175
U2C · FY2025 · OD · contact PI
ECHO Coordinating Center (CC) - Kitting Supplement Resubmission$7,002,175
U2C · FY2025 · OD · contact PI
Oversight and Project Management Component$6,656,303
U2C · FY2025 · OD · contact PI
Coordinating Center Administration Core$5,175,289
U2C · FY2025 · OD · contact PI
ECHO Coordinating Center (CC) - Kitting Expanded Scope$5,175,289
U2C · FY2025 · OD · contact PI
Committee Support and Comm Component$5,112,935
U2C · FY2025 · OD · contact PI
Coordinating Center Administration Core$902,419
U2C · FY2025 · OD · contact PI
ACT_NOW Weaning$700,969
U2C · FY2025 · OD · contact PI
ACT_NOW ESC$310,962
U2C · FY2025 · OD · contact PI
ECHO Coordinating Center (CC) - Administrative Supplement$4,100,000
U2C · FY2024 · OD · contact PI
Environmental influences on Child Health Outcomes (ECHO) Coordinating Center$27,999,994
U2C · FY2023 · OD · contact PI
Oversight and Project Management Component$14,672,132
U2C · FY2023 · OD · contact PI
Committee Support and Comm Component$5,981,514
U2C · FY2023 · OD · contact PI
Coordinating Center Administration Core$2,844,130
U2C · FY2023 · OD · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$999,813
U2C · FY2023 · OD · contact PI
ECHO Coordinating Center$17,857,556
U2C · FY2022 · OD · contact PI
Core Elements and Scientific Focus Areas Coordination Component$10,712,829
U2C · FY2022 · OD · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$1,999,671
U2C · FY2022 · OD · contact PI
ECHO Administrative Supplement - Coordinating Center$1,631,709
U2C · FY2022 · OD · contact PI
ECHO Coordinating Center Administration Core$813,521
U2C · FY2022 · OD · contact PI
ACT-NOW Data Sustainability - ECHO Administrative Supplement$99,877
U2C · FY2022 · OD · contact PI
ECHO Coordinating Center$17,502,857
U2C · FY2021 · OD · contact PI
Core Elements and Scientific Focus Areas Coordination Component$10,623,050
U2C · FY2021 · OD · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$1,500,000
U2C · FY2021 · OD · contact PI
ECHO Coordinating Center Administration Core$725,675
U2C · FY2021 · OD · contact PI
ECHO Coordinating Center$14,970,707
U2C · FY2020 · OD · contact PI
Core Elements and Scientific Focus Areas Coordination Component$8,965,504
U2C · FY2020 · OD · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$7,000,000
U2C · FY2020 · OD · contact PI
ECHO Coordinating Center Administration Core$688,872
U2C · FY2020 · OD · contact PI
ECHO Coordinating Center$7,853,592
U2C · FY2019 · OD · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$6,750,000
U2C · FY2019 · OD · contact PI
Project-002$6,750,000
U2C · FY2019 · OD · contact PI
Core Elements and Scientific Focus Areas Coordination Component$5,093,281
U2C · FY2019 · OD · contact PI
ECHO Coordinating Center Administration Core$396,171
U2C · FY2019 · OD · contact PI
2/5 HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study$271,688
R34 · FY2019 · DA · contact PI
2/5 HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study$271,687
R34 · FY2019 · DA · contact PI
ECHO Coordinating Center$15,926,881
U2C · FY2018 · OD · contact PI
Core Elements and Scientific Focus Areas Coordination Component$9,597,422
U2C · FY2018 · OD · contact PI
ECHO Coordinating Center Administration Core$1,480,785
U2C · FY2018 · OD · contact PI
ECHO Coordinating Center$18,172,311
U2C · FY2017 · OD · contact PI
Project-005$12,872,250
U2C · FY2017 · OD · contact PI
Project-003$4,544,270
U2C · FY2017 · OD · contact PI
Project-002$755,791
U2C · FY2017 · OD · contact PI
Safety of furosemide in premature infants at risk of bronchopulmonary dysplasia$365,227
R01 · FY2017 · FD
ECHO Coordinating Center$14,811,259
U2C · FY2016 · OD · contact PI
Safety of furosemide in premature infants at risk of bronchopulmonary dysplasia$324,857
R01 · FY2016 · FD
PATIENT SAFETY RESEARCH DURING NEONATAL CARE (R21)$197,366
R21 · FY2016 · HD · contact PI
PATIENT SAFETY RESEARCH DURING NEONATAL CARE (R21)$259,170
R21 · FY2015 · HD · contact PI
Efficacy of Antiviral Suppression Therapy after Neonatal HSV Infection of the CNS$249,780
R34 · FY2015 · AI · contact PI
PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN HIGH RISK INFANTS$97,929
K23 · FY2012 · HD · contact PI
PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN HIGH RISK INFANTS$97,929
K23 · FY2011 · HD · contact PI
PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN HIGH RISK INFANTS$124,449
K23 · FY2010 · HD · contact PI
Accelerating Adoption of Comparative Effectiveness Research in Premature Infants$0
R18 · FY2010 · SU · contact PI
PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN HIGH RISK INFANTS$124,449
K23 · FY2009 · HD · contact PI